See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.
Indian pharmaceutical companies are gaining ground in the Chinese market, winning bids to supply bulk generic drugs, including Dapagliflozin for diabetes treatment. Hetero Labs Limited, Cipla Ltd, ...
Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...
The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive ...
The European Commission’s plan to use joint procurement to provide access to innovative drugs across the bloc risks overuse ...
On October 29, 2025, the U.S. Food and Drug Administration (FDA), in coordination with the Department of Health and Human Services (HHS) and ...
This case study demonstrates how advanced NMR spectroscopy enables high-resolution structural characterization of exenatide.
The FDA's recall pertains to several lots of lisdexamfetamine dimesylate capsules that failed to meet essential dissolution tests. Dissolution is a crucial process in pharmacology that determines how ...
Research on adults who take S.S.R.I.s shows they tamp down sexual desire. Why aren’t we studying what that could mean for ...
Delhi, Himachal Pradesh and Uttarakhand are among the states that have already initiated action, the people said. The ...
The White House may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results